Fibroid surgery showdown: which operation spares your pelvic floor?
NCT ID NCT07180524
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 200 women having surgery for symptomatic uterine fibroids to see how their pelvic floor changes over a year. Half will have a hysterectomy, half a myomectomy. Researchers will measure pelvic floor structure and symptoms at 1, 6, and 12 months after surgery. The goal is to understand which operation better preserves pelvic floor health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose the best surgical approach for uterine fibroids to minimize pelvic floor problems.
- What could go wrong
- This is an observational study, not a treatment trial. It will not prove which surgery is better, only describe differences. Results may not apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with symptomatic uterine fibromatosis and candidates for surgical treatment aged between 40 and 55 years will be consecutively enrolled.
- Ages
-
35 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Symptomatic uterine fibromatosis with intramural and/or subserosal myomas identified by ultrasound and topographically mapped * Patients with scheduled hysterectomy or myomectomy Exclusion Criteria: * suspicion of malignant lesion. * active tumors * previous history of chemotherapy or radiotherapy * pregnancy * age \<18 years or \>55 years (postmenopause) * history of pelvic static disorders prior to surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fibromatosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia 1
RECRUITINGPavia, Pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a child's walk reveal hidden pelvic floor troubles? a study investigates.
- Can a simple exercise routine restore pelvic floor strength after birth?
- New study aims to uncover reproductive health challenges in female canadian forces
- Can your pelvic muscles predict your delivery?
- New study tests pelvic floor training for new moms
- Simple exercises during pregnancy may prevent severe birth tears